BIIB vs LNTH
Biogen vs Lantheus Holdings — AI-powered side-by-side comparison
VS
LNTH
Lantheus Holdings
66
Buy
| Metric | BIIB | LNTH |
|---|
| AI Score |
67
|
66
|
| Price |
$208.02
|
$100.97
|
| P/E Ratio |
36.61×
|
23.98×
|
| ROE |
7.1%
|
21.4%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
67.7%
|
60.1%
|
| Debt / Equity |
0.44×
|
0.44×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
56.7
|
42.4
|
| Beta |
0.158
|
-0.057
|
| Expected Upside |
+5.2%
|
+7.9%
|
AI Committee View
Current Innellis committee reasoning for BIIB versus LNTH.
BIIB leads by 1 points.
BIIB scores 67/100 (Buy) versus LNTH at 66/100 (Buy).
BIIB Committee View
80% agreement
5 analysts
The primary driver is news sentiment is positive (+0.42 across 47 articles, 14d). The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
LNTH Committee View
75% agreement
4 analysts
The primary driver is 3 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- 3 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- MACD histogram negative -- bearish momentum — Technical